Petit Lady offers non-surgical vaginal rejuvenation

25 Jun 2014

A new product offering women vaginal rejuvenation, without surgery, will be launched in the UK later this year. Lutronic’s Action II Petit Lady has received CE mark clearance for the treatment of vaginal relaxation syndrome (VRS) and stress urinary incontinence (SUI). International sales director of Lutronic, Mr S Ko, said, “The market opportunity for Action II Petit Lady procedure in developed countries is substantial and we’re looking forward to establishing our presence in Europe.”

A new product offering women vaginal rejuvenation, without surgery, will be launched in the UK later this year.

Lutronic’s Action II Petit Lady has received CE mark clearance for the treatment of vaginal relaxation syndrome (VRS) and stress urinary incontinence (SUI).

International sales director of Lutronic, Mr S Ko, said, “The market opportunity for Action II Petit Lady procedure in developed countries is substantial and we’re looking forward to establishing our presence in Europe.”

The original Action II technology was used to treat dermatological issues such as scars, epidermal benign disorder and epidermal pigment lesions, and the company are now focusing on expanding its clinical application.

Lutronic, an innovator in laser technology, claim the HD edition will enable doctors to effectively treat a wide range of vulva-vaginal conditions such as VRS, common after childbirth and in older women.

Action II is an Erbium YAG laser that aims to treat the target area with micron-level precision and very little thermal conduction, aiming to be as comfortable as possible for the patient.

Ko said, “The dual mode has overcome traditional Erbium YAG laser’s limitations and accumulates more controllable thermal effect to target tissues.”

Lutronic claim that the laser tightens vaginal tissues, remodels collagen and rejuvenates the vulva to revive the sensations while revitalizing the tissues of the vagina.

Action II Petit Lady has already been successful in both Asia and the Middle East.

 

Comments

Log-in to post a comment